Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl; Joachim H. Ficker; Gloria Zeitler

doi:10.1186/s12885-020-07690-8

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).

Wolfgang M Brueckl^* (First author), Joachim H. Ficker (Co-author), Gloria Zeitler

^*Corresponding author for this work

Department of Internal Medicine III, Division of Respiratory Medicine, Allergology and Sleep Medicine

Research output: Contribution to journal › Review article › peer-review

83 Citations (Web of Science)

Original language	English
Pages (from-to)	1185
Journal	BMC CANCER
Volume	20
Issue number	1
DOIs	https://doi.org/10.1186/s12885-020-07690-8
Publication status	Published - 2020

Keywords

ENDOTHELIAL GROWTH-FACTOR
OPEN-LABEL
INFLAMMATORY BIOMARKERS
SYSTEMIC THERAPY
LYMPHOCYTE RATIO
PLEURAL EFFUSION
POOLED ANALYSIS
FACTOR VEGF
STAGE IV
DOCETAXEL

Access to Document

10.1186/s12885-020-07690-8

Cite this

@article{f83ef23719ea42d99593110f9bad14f2,

title = "Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).",

keywords = "ENDOTHELIAL GROWTH-FACTOR, OPEN-LABEL, INFLAMMATORY BIOMARKERS, SYSTEMIC THERAPY, LYMPHOCYTE RATIO, PLEURAL EFFUSION, POOLED ANALYSIS, FACTOR VEGF, STAGE IV, DOCETAXEL",

author = "Brueckl, {Wolfgang M} and Ficker, {Joachim H.} and Gloria Zeitler",

note = "all: Paracelsus Medical Private University Nuremberg, Prof.-Ernst-Nathan-Str. 1, 90419, Nuremberg, Germany",

year = "2020",

doi = "10.1186/s12885-020-07690-8",

language = "English",

volume = "20",

pages = "1185",

journal = "BMC CANCER",

issn = "1471-2407",

publisher = " BioMed Central",

number = "1",

}

TY - JOUR

T1 - Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC).

AU - Brueckl, Wolfgang M

AU - Ficker, Joachim H.

AU - Zeitler, Gloria

N1 - all: Paracelsus Medical Private University Nuremberg, Prof.-Ernst-Nathan-Str. 1, 90419, Nuremberg, Germany

PY - 2020

Y1 - 2020

KW - ENDOTHELIAL GROWTH-FACTOR

KW - OPEN-LABEL

KW - INFLAMMATORY BIOMARKERS

KW - SYSTEMIC THERAPY

KW - LYMPHOCYTE RATIO

KW - PLEURAL EFFUSION

KW - POOLED ANALYSIS

KW - FACTOR VEGF

KW - STAGE IV

KW - DOCETAXEL

U2 - 10.1186/s12885-020-07690-8

DO - 10.1186/s12885-020-07690-8

M3 - Review article

C2 - 33272262

SN - 1471-2407

VL - 20

SP - 1185

JO - BMC CANCER

JF - BMC CANCER

IS - 1

ER -